|
May 3
|
Agios Pharmaceuticals Inc (AGIO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
|
|
May 3
|
Q1 2024 Agios Pharmaceuticals Inc Earnings Call
|
|
May 2
|
Agios Pharmaceuticals Reports Q1 2024 Earnings: Narrower Loss than Expected with Strong Revenue ...
|
|
May 2
|
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 2
|
Agios Reports Business Highlights and First Quarter 2024 Financial Results
|
|
Apr 30
|
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 25
|
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 18
|
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
|
|
Apr 16
|
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
|
|
Apr 10
|
Director Jacqualyn Fouse Sells Shares of Agios Pharmaceuticals Inc (AGIO)
|
|
Apr 9
|
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
|
|
Mar 30
|
We Think Agios Pharmaceuticals (NASDAQ:AGIO) Can Afford To Drive Business Growth
|
|
Mar 5
|
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
|
|
Jan 12
|
Insider Sell: CEO Brian Goff Sells 12,066 Shares of Agios Pharmaceuticals Inc (AGIO)
|
|
Jan 2
|
Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
|
|
Dec 10
|
Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition
|
|
Dec 6
|
Agios Pharmaceuticals (NASDAQ:AGIO) shareholders have endured a 59% loss from investing in the stock five years ago
|
|
Nov 5
|
Calculating The Fair Value Of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
|
|
Nov 3
|
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Agios (AGIO) Reports Narrower-Than-Expected Q3 Loss, Lags Sales
|